Valbiotis SA (FR:ALVAL) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Valbiotis, a French firm specializing in health nutrition products to combat metabolic disorders, reported its voting rights and share capital structure as of July 31, 2024, listing 15,794,596 shares and over 16 million voting rights. The company, noted for its innovative approach utilizing both terrestrial and marine plants, aims to reduce cardiovascular risks through its product line. It maintains a robust research presence in France and a subsidiary in Canada, supported by European Union funds and recognized by BPI France.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.